NLM Logo

pegvisomant MeSH Supplementary Concept Data 2021


MeSH Supplementary
pegvisomant
Unique ID
C406545
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C406545
Entry Term(s)
B-2036 PEG
B2036-PEG
Somavert
Registry Number
N824AOU5XV
Heading Mapped to
Human Growth Hormone / *analogs & derivatives
Frequency
405
Note
is a genetically engineered analogue of human growth hormone that functions as a growth hormone-receptor antagonist; used to treat Acromegaly;
Source
N Engl J Med 2000 Apr 20;342(16):1171-7
Indexing Information
Acromegaly
Receptors, Somatotropin
Date of Entry
2000/04/18
Revision Date
2016/08/26
pegvisomant Preferred
B2036-PEG Narrower
Somavert Narrower
page delivered in 0.006s